AAIC 2025 Abstract·9 Jan[ ¹⁸ F]SMBT‐1 PET as an Imaging Biomarker for Reactive Astrogliosis in Mild Cognitive Impairment and Alzheimer's DiseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·26 DecChanges in the population of patients with dementia referred to Dementia disease centers in Japan as a result of the launch of LecanemabStudy in peoplePopulationsPaper
AAIC 2025 Abstract·23 Dec[ ¹⁸ F]SMBT‐1 PET as an Imaging Biomarker for Reactive Astrogliosis in Mild Cognitive Impairment and Alzheimer's DiseaseStudy in peopleBiomarkersPaper